Berit Müller

5.7k total citations · 1 hit paper
43 papers, 3.3k citations indexed

About

Berit Müller is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Berit Müller has authored 43 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Berit Müller's work include HER2/EGFR in Cancer Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Berit Müller is often cited by papers focused on HER2/EGFR in Cancer Research (7 papers), Cancer Genomics and Diagnostics (6 papers) and Metabolomics and Mass Spectrometry Studies (5 papers). Berit Müller collaborates with scholars based in Germany, United States and Finland. Berit Müller's co-authors include Carsten Denkert, Manfred Dietel, Jan Budczies, Wilko Weichert, Silvia Darb‐Esfahani, Aurelia Noske, Sibylle Loibl, Gϋnter von Minckwitz, Marc Roller and Ralf Kronenwett and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Berit Müller

43 papers receiving 3.3k citations

Hit Papers

Tumor-Associated Lymphocytes As an Independent Predictor ... 2009 2026 2014 2020 2009 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berit Müller Germany 26 1.9k 1.3k 1.3k 671 420 43 3.3k
Theodoros Foukakis Sweden 33 2.1k 1.1× 1.5k 1.1× 1.4k 1.1× 719 1.1× 726 1.7× 135 4.1k
Giulio Francia United States 31 1.5k 0.8× 849 0.7× 1.5k 1.2× 346 0.5× 540 1.3× 69 3.2k
John M.L. Ebos United States 23 1.6k 0.9× 1.5k 1.2× 2.3k 1.9× 411 0.6× 711 1.7× 49 4.1k
Ewan K.A. Millar Australia 33 1.3k 0.7× 1.1k 0.9× 1.8k 1.4× 297 0.4× 525 1.3× 80 3.4k
Anita Mangia Italy 29 1.2k 0.6× 797 0.6× 1.4k 1.1× 300 0.4× 407 1.0× 108 2.7k
Emma C. Paish United Kingdom 26 2.7k 1.4× 1.2k 1.0× 1.2k 1.0× 1.3k 2.0× 538 1.3× 43 4.1k
Marleen Kok Netherlands 30 2.3k 1.2× 887 0.7× 1.1k 0.9× 953 1.4× 817 1.9× 90 3.6k
José Manuel Pérez-García Spain 26 2.0k 1.0× 891 0.7× 1.5k 1.2× 356 0.5× 962 2.3× 110 3.5k
Rafał Matkowski Poland 28 1.2k 0.6× 696 0.5× 865 0.7× 363 0.5× 316 0.8× 183 2.3k
Wentao Yang China 34 1.7k 0.9× 1.2k 0.9× 1.4k 1.1× 381 0.6× 590 1.4× 173 3.8k

Countries citing papers authored by Berit Müller

Since Specialization
Citations

This map shows the geographic impact of Berit Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit Müller more than expected).

Fields of papers citing papers by Berit Müller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berit Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit Müller. The network helps show where Berit Müller may publish in the future.

Co-authorship network of co-authors of Berit Müller

This figure shows the co-authorship network connecting the top 25 collaborators of Berit Müller. A scholar is included among the top collaborators of Berit Müller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berit Müller. Berit Müller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Berit, Jens Weibezahn, & Frauke Wiese. (2018). Energy Modelling: A Quest for a more Open and Transparent Approach. 8(2). 18–24. 2 indexed citations
3.
Denkert, Carsten, Sibylle Loibl, Berit Müller, et al.. (2013). Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial. Annals of Oncology. 24(11). 2786–2793. 172 indexed citations
4.
Denkert, Carsten, Sibylle Loibl, Ralf Kronenwett, et al.. (2012). RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy. Annals of Oncology. 24(3). 632–639. 19 indexed citations
5.
Müller, Berit, Jan C. Brase, Karsten E. Weber, et al.. (2012). Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections. Journal of Clinical Pathology. 65(7). 660–662. 25 indexed citations
6.
Kronenwett, Ralf, Kerstin Bohmann, Judith Prinzler, et al.. (2012). Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test. BMC Cancer. 12(1). 456–456. 50 indexed citations
7.
Budczies, Jan, Wilko Weichert, Aurelia Noske, et al.. (2011). Genome-wide Gene Expression Profiling of Formalin-fixed Paraffin-Embedded Breast Cancer Core Biopsies Using Microarrays. Journal of Histochemistry & Cytochemistry. 59(2). 146–157. 27 indexed citations
8.
Brockmöller, Scarlet, Elmar Bucher, Berit Müller, et al.. (2011). Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer—Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling. Journal of Proteome Research. 11(2). 850–860. 59 indexed citations
9.
Denkert, Carsten, Bruno V. Sinn, Yasmin Issa, et al.. (2011). Prediction of Response to Neoadjuvant Chemotherapy: New Biomarker Approaches and Concepts. Breast Care. 6(4). 265–272. 15 indexed citations
10.
Budczies, Jan, Carsten Denkert, Berit Müller, et al.. (2010). METAtarget - Extracting Key Enzymes of Metabolic Regulation from Highthroughput Metabolomics Data using KEGG REACTION Information.. 103–112. 1 indexed citations
11.
Noske, Aurelia, Sibylle Loibl, Silvia Darb‐Esfahani, et al.. (2010). Comparison of different approaches for assessment of HER2 expression on protein and mRNA level: prediction of chemotherapy response in the neoadjuvant GeparTrio trial (NCT00544765). Breast Cancer Research and Treatment. 126(1). 109–117. 47 indexed citations
12.
Darb‐Esfahani, Silvia, Bruno V. Sinn, Wilko Weichert, et al.. (2010). Expression of classical NF‐κB pathway effectors in human ovarian carcinoma. Histopathology. 56(6). 727–739. 27 indexed citations
13.
Kasajima, Atsuko, Christine Sers, Hironobu Sasano, et al.. (2010). Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer. Human Pathology. 41(12). 1758–1769. 60 indexed citations
15.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Topoisomerase IIα mRNA and protein expression in ovarian carcinoma: correlation with clinicopathological factors and prognosis. Modern Pathology. 22(4). 579–588. 32 indexed citations
16.
Faggad, Areeg, Silvia Darb‐Esfahani, Ralph M. Wirtz, et al.. (2009). Expression of multidrug resistance‐associated protein 1 in invasive ovarian carcinoma: implication for prognosis. Histopathology. 54(6). 657–666. 24 indexed citations
17.
Lehmann, Annika, Carsten Denkert, Jan Budczies, et al.. (2009). High class I HDAC activity and expression are associated with RelA/p65 activation in pancreatic cancer in vitro and in vivo. BMC Cancer. 9(1). 395–395. 75 indexed citations
18.
Noske, Aurelia, Areeg Faggad, Silvia Darb‐Esfahani, et al.. (2009). IMP3 Expression in Human Ovarian Cancer is Associated With Improved Survival. International Journal of Gynecological Pathology. 28(3). 203–210. 25 indexed citations
19.
Faggad, Areeg, Jan Budczies, Oleg Tchernitsa, et al.. (2009). Prognostic significance of Dicer expression in ovarian cancer—link to global microRNA changes and oestrogen receptor expression. The Journal of Pathology. 220(3). 382–391. 74 indexed citations
20.
Darb‐Esfahani, Silvia, Areeg Faggad, Aurelia Noske, et al.. (2008). Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro. Journal of Cancer Research and Clinical Oncology. 135(7). 933–941. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026